Cutler Group LP Iovance Biotherapeutics, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$7.59 - $17.47 $160,908 - $370,364	21,200 New	21,200 $6,000
Q3 2023 Nov 07, 2023	BUY	$4.44 - $8.79 $15,540 - $30,764	3,500 New	3,500 $10,000
Q3 2022 Oct 25, 2022	SELL	$9.53 - $13.11 $4,765 - $6,555	-500 Reduced 45.45%	600 $1,000
Q2 2022 Aug 04, 2022	SELL	$6.38 - $18.33 $150,568 - $432,587	-23,600 Reduced 95.55%	1,100 $2,000
Q1 2022 Apr 14, 2022	BUY	$12.38 - $19.1 $252,552 - $389,640	20,400 Added 474.42%	24,700 $13,000
Q4 2021 Jan 18, 2022	SELL	$16.55 - $27.63 $862,255 - $1.44 Million	-52,100 Reduced 92.38%	4,300 $12,000
Q3 2021 Oct 26, 2021	BUY	$20.35 - $26.63 $807,895 - $1.06 Million	39,700 Added 237.72%	56,400 $97,000
Q2 2021 Jul 19, 2021	BUY	$16.33 - $33.07 $262,913 - $532,427	16,100 Added 2683.33%	16,700 $18,000
Q1 2021 Apr 26, 2021	SELL	$28.67 - $52.59 $71,675 - $131,475	-2,500 Reduced 80.65%	600 $1,000
Q4 2020 Jan 21, 2021	BUY	$28.04 - $50.26 $56,080 - $100,520	2,000 Added 181.82%	3,100 $0
Q3 2020 Oct 27, 2020	SELL	$27.75 - $36.3 $130,425 - $170,610	-4,700 Reduced 81.03%	1,100 $4,000
Q2 2020 Jul 22, 2020	BUY	$27.21 - $41.0 $68,025 - $102,500	2,500 Added 75.76%	5,800 $9,000
Q1 2020 May 07, 2020	BUY	$19.54 - $38.85 $60,574 - $120,435	3,100 Added 1550.0%	3,300 $16,000
Q2 2019 Aug 09, 2019	BUY	$9.78 - $24.52 $1,955 - $4,904	200 New	200 $0
Q2 2018 Aug 10, 2018	SELL	$12.45 - $16.95 $12,450 - $16,950	-1,000 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$8.1 - $19.5 $7,290 - $17,550	-900 Reduced 47.37%	1,000 $0
Q4 2017 Jan 17, 2018	BUY	$6.65 - $9.25 $5,985 - $8,325	900 Added 90.0%	1,900 $3,000
Q3 2017 Oct 17, 2017	BUY	$4.45 - $8.55 $4,450 - $8,550	1,000	1,000 $0

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account